News Conference News ACC 2022 PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization L.A. McKeown April 03, 2022
Presentation ACC 2022 Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Presenter: Milind Y Desai April 03, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022
News Conference News ACC 2022 Seasonal, but No Year-round Help for HF With Flu Shots: IVVE Yael L. Maxwell April 03, 2022
News Conference News ACC 2022 SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization L.A. McKeown April 02, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2022 Caitlin E. Cox April 01, 2022
News Daily News A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients Caitlin E. Cox March 31, 2022
News Daily News Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’ Michael O'Riordan March 28, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Daily News Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia L.A. McKeown March 22, 2022
News Daily News Heart Transplant Recipients Fare Poorer When Stroke Is Cause of Death for Younger Donors Yael L. Maxwell March 17, 2022
News Daily News Guideline-Directed Therapies Underused in Frail HF Patients L.A. McKeown March 11, 2022
News Daily News Skipping Low-Value Cardiovascular Care Could Save Billions: AHA Michael O'Riordan March 01, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2022 Shelley Wood February 28, 2022
News Daily News Skipping Second Dose of mRNA COVID-19 Vaccine May Limit Myocarditis in Adolescents Todd Neale February 25, 2022
News Daily News AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis Yael L. Maxwell February 24, 2022
News Daily News FDA Approves Empagliflozin for Treatment of HFpEF Michael O'Riordan February 24, 2022